Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kendle Gets Approval for India Center | Contract Pharma
Breaking News

Kendle Gets Approval for India Center

Kendle received approval from Indian authorities to proceed with development of a new operations center in a Special Economic Zone (SEZ) in the Ahmedabad-Gandhinagar Knowledge Corridor.

Kendle received approval from Indian authorities to proceed with development of a new operations center in a Special Economic Zone (SEZ) in the Ahmedabad-Gandhinagar Knowledge Corridor. The new SEZ center is part of the company’s strategic plan to further invest in Asia/Pacific to meet customer needs. The new unit is expected to be operational in April.

“Continued expansion throughout the Asia/Pacific region is crucial to the future growth of Kendle,” said Stephen Cutler, Ph.D., senior vice president and chief operating officer. “Our increased capacity in the region will allow us to better meet the growing demands of our customers who are seeking to capitalize on India’s rapidly expanding high-quality biopharmaceutical capabilities. The new SEZ operations center will be ideally suited to deliver best-in-class services to our customers seeking high-quality, innovative and cost-effective solutions for their clinical development needs.”

The SEZ operations center will focus on quality delivery of clinical data management, medical writing, pharmacovigilance/safety, biostatistics/programming and other knowledge processing-related services. Initially the center will house approximately 50 associates and is expected to scale up to approximately 300 associates in the near term.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters